TITLE

Left forearm pain

AUTHOR(S)
Lee, Wei-Jing; Lei, Jung-Chun; Yang, Po-Jen
PUB. DATE
December 2010
SOURCE
QJM: An International Journal of Medicine;Dec2010, Vol. 103 Issue 12, p995
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
55370401

 

Related Articles

  • Forearm blood flow measured by venous occlusion plethysmography in healthy subjects and in women with postmastectomy oedema. Stanton, A.A.W.B.; Mortimer, P.P.S.; Holroyd, B.; Northfield, J.J.W.; Levick, R.J.R. // Vascular Medicine;1998, Vol. 3 Issue 1, p3 

    A chronic swelling of the arm may develop following damage to axillary lymph vessels during breast cancer treatment. Certain unusual pathophysiological features of postmastectomy oedema indicate that factors additional to lymphatic damage are important. One factor postulated previously is a...

  • Augmented Fragmentation of Atrial Activity Upon Premature Electrical Stimuli by Verapamil. Aizawa, Y.; Miyajima, S.; Niwano, S.; Tamura, M.; Shibata, A. // Angiology;Feb1989, Vol. 40 Issue 2, p94 

    The significance of fragmented activity obtained from the atrium during electrophysiologic study (EP study) was confirmed since it was always observed just at the onset of fibrillation. It was preceded by extra stimuli or atrial flutter, and the initial site of fragmentation varied from case to...

  • Brugada Syndrome Unmasked by Pneumonia. Sovari, Ali A.; Prasun, Marylin A.; Kocheril, Abraham G.; Brugada, Ramon // Texas Heart Institute Journal;2006, Vol. 33 Issue 4, p501 

    A 69-year-old white woman presented at our emergency room with right-side pleuritic chest pain, fever, and tachycardia. Results of the physical examination, routine laboratory tests, and chest radiography were unexceptional. An electrocardiogram showed ST elevation in leads V[sub 1] through...

  • Kontrolsüz Warfarin Kullanımına BaÄŸlı GeliÅŸen Yaygın Alveoler Hemoraji: Olgu Sunumu. Akagün, Tülin; Güngör, Erdal; Akdogan, Elif; Bülbül, Yilmaz; Sönmez, Mehmet // International Journal of Hematology & Oncology / UHOD: Uluslarar;Sep2008, Vol. 18 Issue 3, p170 

    Warfarin; one of the most common oral anticoagülant drug is used for treatment of thromboembolic events and also for prevention of thromboembolic complications in atrial fibrillation and other cardiovascular diseases. The most important adverse effect is hemorrhage. Diffuse alveolar...

  • Iatrogenic Superficial External Pudendal Artery Pseudoaneurysm: Treatment with Doppler US-Guided Compression. Algin, Oktay; Mustafayev, Assanaly; Ozmen, Evrim // Iranian Journal of Radiology;Jun2014, Vol. 11 Issue 2, p1 

    Pseudoaneurysms rarely occur as a serious complication following incomplete hemostasis of an arterial puncture site. As a result of the increase in diagnostic and therapeutic angiography, the frequency of iatrogenic pseudoaneurysm has increased as well. Iatrogenic pseudoaneurysms associated with...

  • Posttraumatic Pedal Artery Pseudoaneurysm: A Case Report. Irarrazaval, Cristián Arriagada; Gross, Ricardo Sonneborn; Maritano, Alexandre Sauré; Diez, Carolina Soto // Case Reports in Vascular Medicine;2012, p1 

    Pseudoaneurysm of the pedal artery is usually caused by traumatic or iatrogenic events. Diagnosis is suspected by palpation of a pulsatile mass and detection of an associated systolic bruit. Confirmation is made by Doppler US. Angiography can demonstrate the presence of collateral circulation...

  • Pseudoaneurysm of peroneal artery after ankle arthroscopy. Battisti, Daniela; Oliva, Francesco; Tarantino, Umberto; Nicola, Maffulli // Muscles, Ligaments & Tendons Journal (MLTJ);2014 Supplement, p269 

    Background: ankle arthroscopy increased its role in the diagnosis and treatment of pathology of the ankle since 1970s. Although the benefits are well established, ankle arthroscopy is associated with a definite risk of complications, especially neurological. The incidence rate of vascular...

  • Clinical trial data on the cardioprotective effects of beta-blockade. Kendall, M. J. // Basic Research in Cardiology;Nov2000 Supplement 1, Vol. 95, pI25 

    In most patients with heart failure the underlying cause is coronary artery disease (CAD). They have a poor prognosis and die slowly from deteriorating cardiac function or suddenly from ventricular fibrillation or atheromatous plaque rupture. Two key aims of treatment, therefore, are to slow the...

  • ACE inhibitors in heart failure: an update. Smith, W. H. T.; Ball, S. G. // Basic Research in Cardiology;Nov2000 Supplement 1, Vol. 95, pI8 

    Angiotensin-converting enzyme (ACE) inhibitors are now accepted as part of the routine management of patients with heart failure. Their use has been mandated in all the new major mortality trials to test the efficacy of β-blockers in heart failure. Morbidity and mortality remain high in those...

Share

Read the Article

Courtesy of MICHIGAN ELIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics